Compare Cytokinetics Inc (CYTK) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Nebius Group NV — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Nebius Group NV trades at $225.18 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 4.6× Cytokinetics Inc's market cap. Which is the better fit depends on your goals.
| CYTK | NBIS | |
|---|---|---|
Market Cap | $10.63B | $49.06B |
Sector | Technology | Technology |
52-Week High | $87.26 | $286.69 |
52-Week Low | $34.31 | $64.06 |
Enterprise Value | $10.74B | $49.26B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
